While its revenue trajectory points upward, battery innovator Enovix continues to consume significant cash as it builds towards high-volume manufacturing. The company’s latest annual figures revealed substantial growth, yet this positive signal is tempered by persistent operational losses and a deteriorating technical chart pattern. Investor attention is now fixed on the impending commercialization of its technology in consumer electronics, specifically smartphones and wearable devices.
Manufacturing Expansion Demands Heavy Investment
The financial results for the full year 2025 underscore Enovix’s transitional phase. Annual revenue reached $31.8 million, marking a 38% increase over the prior year. This growth was primarily driven by shipments to military and industrial clients. However, management has moderated expectations for the ongoing first quarter of 2026, forecasting seasonal revenue to be in the range of just $6.5 to $7.5 million.
Concurrently, the company anticipates an operational loss of up to $32 million for the same quarter. The capital requirements are substantial, with the expansion of its “Fab2” production facility alone necessitating equipment investments of up to $11 million in Q1.
Should investors sell immediately? Or is it worth buying Enovix?
This financial strain is visibly reflected in the stock’s performance. Currently trading at €4.55, the equity has shed more than 32% of its value since the start of the year and remains positioned well below its key 200-day moving average. Technical indicators continue to signal weakness, and from a fundamental perspective, traditional valuation metrics currently classify the stock as expensive due to its lack of profitability.
Smart Eyewear Emerges as a Near-Term Catalyst
To justify its valuation in the future, Enovix is progressing with the qualification of its silicon-anode batteries for mass-market adoption. Advanced lifecycle and safety testing is currently underway with a major smartphone sector customer. A broader commercial rollout within this high-margin segment, however, is not scheduled until late 2026 or early 2027.
A nearer-term opportunity lies in batteries for smart glasses designed for AI and augmented reality applications. The company states its cells already meet the technical specifications for this use case. Consequently, Enovix plans to initiate initial shipments for this market in the second half of 2026. Management estimates the addressable market for smart eyewear batteries could exceed $400 million by 2030. Until these new markets begin generating significant income, the company’s focus remains rigidly fixed on the timely execution of its manufacturing capacity build-out.
Ad
Enovix Stock: Buy or Sell?! New Enovix Analysis from March 30 delivers the answer:
The latest Enovix figures speak for themselves: Urgent action needed for Enovix investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 30.
Enovix: Buy or sell? Read more here...
